首页> 外国专利> METHOD FOR PREDICTING BRONCHIAL ASTHMA CLINICAL DEVELOPMENT SEVERITY IN ADOLESCENT PATIENT AT PUBERTY TRANSITION TIME

METHOD FOR PREDICTING BRONCHIAL ASTHMA CLINICAL DEVELOPMENT SEVERITY IN ADOLESCENT PATIENT AT PUBERTY TRANSITION TIME

机译:过渡期青少年患者支气管哮喘临床发展严重程度的预测方法

摘要

FIELD: medicine.;SUBSTANCE: method involves determining thyroid gland hormone of triiodothyronine (T3 in IU/l) and thyroxin (T4 in IU/l), pituitary hormones - thyrotropic hormone (TTH in IU/l), follicle-stimulating hormone (FSH in IU/l) and luteinizing hormone (LH in IU/l) concentration using radio isotope method and physical adolescent growth and development level with somatometric type being equal to 1 in microsomatic type cases, 2 in mesosomatic type cases and 3 in macrosomatic type cases. Discriminant function is determined in male adolescent case as D=19.535x(T3)+3.973x(T4)-27.38x(TTH)-11.028x(1.2 or 3)-307.473x(FSH)-17.585x(LH). The discriminant function value D116.44 being the case, worsening bronchial asthma clinical course is predicted. D116.44 being the case, bronchial improving asthma clinical course is predicted. Discriminant function is determined in female adolescent case as D=-4.908x(T3)-0.052x(T4)-0.355x(TTH)-3.166x(1.2 or 3)-0.769x(FSH)-0.144x(LH). The discriminant function value D-24.23 being the case, worsening bronchial asthma clinical course is predicted. D-24.23 being the case, improving bronchial asthma clinical course is predicted.;EFFECT: high accuracy in detecting severe bronchial asthma adolescent risk group.
机译:领域:药物;方法:该方法涉及测定垂体激素三碘甲状腺素(IU / l中的T 3 )和甲状腺素(IU / l中的T 4 )的甲状腺激素-使用放射性同位素法测定的促甲状腺激素(TTH,单位:IU / l),促卵泡激素(FSH,单位:IU / l)和促黄体生成激素(LH,单位:IU / l),以及青春期体格类型等于生理上的青少年生长和发育水平在微粒体型病例中为1,在微粒体型病例中为2,在宏观体型病例中为3。在男性青少年中判别函数为D = 19.535x(T 3 )+ 3.973x(T 4 )-27.38x(TTH)-11.028x(1.2或3)-307.473x(FSH)-17.585x(LH)。在这种情况下,判别函数值D> 116.44,预示着支气管哮喘临床病情恶化。在D <116.44的情况下,预测支气管改善哮喘的临床过程。在女性青少年情况下判别功能为D = -4.908x(T 3 )-0.052x(T 4 )-0.355x(TTH)-3.166x(1.2或3)-0.769x(FSH)-0.144x(LH)。在这种情况下,判别函数值D> -24.23,预示着支气管哮喘临床病情恶化。 D <-24.23,预示着支气管哮喘临床病程的改善。;效果:对重症支气管哮喘青少年高危人群的检测具有较高的准确性。

著录项

  • 公开/公告号RU2273856C1

    专利类型

  • 公开/公告日2006-04-10

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU20040131432

  • 申请日2004-10-27

  • 分类号G01N33/74;A61B5/107;

  • 国家 RU

  • 入库时间 2022-08-21 21:21:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号